Securities Fraud Investigation Into Biohaven Ltd. (BHVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BIOHAVEN LTD. (BHVN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On July 27, 2023, Biohaven disclosed that the FDA had rejected the New Drug Application ('NDA') for its spinocerebellar ataxia ('SCA') treatment, troriluzole, having refused to even review the application after the Phase 3 SCA Trial had failed to meet its primary endpoint. On this news, Biohaven's stock price fell $5.38, or 22.6%, to close at $18.42 per share on July 27, 2023, thereby injuring investors.
Then, on March 3, 2025, Biohaven released its fourth quarter and full year 2024 financial results, disclosing that recent data from a late-stage study of its BHV-7000 treatment for bipolar mania 'did not statistically separate from the comparator on the Young Mania Rating Scale primary outcome measure[.]' On this news, Biohaven's stock price fell $5.12, or 13.8%, to close at $32.06 per share on March 3, 2025.
Then, on April 25, 2025, news reports emerged that, according to the European Medicines Agency ('EMA'), Biohaven had withdrawn its Marketing Authorization Application ('MAA') for troriluzole in late March 2025. On this news, Biohaven's stock price fell $3.56, or 15.2%, to close at $19.84 per share on April 25, 2025.
Then, on May 14, 2025, Biohaven announced that 'the Division of Neurology 1 within FDA's Office of Neuroscience informed the Company that they are extending the [Prescription Drug User Fee Act ('PDUFA')] date for the troriluzole [NDA] for the treatment of [SCA] by three months to provide time for a full review of Biohaven's recent submissions related to information requests from the FDA,' and that '[t]he Division also informed Biohaven that it is currently planning to hold an advisory committee meeting to discuss the application, but no date has been scheduled.' On this news, Biohaven's stock price fell $3.84, or 19.5%, to close at $15.82 per share on May 15, 2025, thereby injuring investors further.
Contact Us To Participate or Learn More:
If you purchased Biohaven securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Century City, California 90067
Call us at: 310-914-5007
Email us at: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com.
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Cemex SAB de CV (CX) Q2 2025 Earnings Call Highlights: Strong Net Income Growth and Strategic ...
EBITDA Savings: Expected to reach $200 million for the year, with a run rate of $400 million by 2027. Net Income: Increased by 38% due to strong FX rates and lower interest expense. Free Cash Flow from Operations: Slightly over $200 million for the quarter. Energy Costs: Declined by 14% on a ton of cement basis. Leverage Ratio: Stood at 2.05 times as of June. Revenue from Discontinued Operations: Contributed to record debt income of $1.05 billion for the first six months. Pricing Strategy: Cement, ready-mix, and aggregate prices increased by 5%, 6%, and 8% respectively since the beginning of the year. US Aggregate Prices: Increased by 5% in the first half compared to Q4 2024. EMEA Region Performance: Achieved highest first half EBITDA in recent history with a margin expansion of almost 3% points. Mexican Peso Hedging Strategy: Fully covers operating cash flow for Mexico. Interest Expense Reduction: Expected to decline by $125 million in 2025. Warning! GuruFocus has detected 7 Warning Sign with CX. Release Date: July 24, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cemex SAB de CV (NYSE:CX) exceeded internal expectations for the second quarter, with consolidated EBITDA outperforming projections. The company has implemented a strategic plan focused on operational excellence and shareholder returns, which includes a comprehensive roadmap and a new capital allocation model. Cemex SAB de CV (NYSE:CX) anticipates significant EBITDA savings, expecting $200 million in 2025 and a run rate of $400 million by 2027, primarily from headcount reductions and operational efficiencies. The EMEA region showed strong performance with volume recovery and margin expansion, marking four consecutive quarters of earnings recovery. The company is optimistic about future growth, particularly in the US and Europe, driven by infrastructure projects and strategic M&A transactions aimed at boosting earnings. Negative Points Cemex SAB de CV (NYSE:CX) faced challenges in Mexico due to difficult prior year comparisons and high levels of precipitation affecting volumes. The US market experienced a decline in volumes due to high precipitation and continued weakness in the residential sector. The Mexican peso remained a headwind, impacting EBITDA despite some offset from other currency appreciations. Free cash flow from operations was affected by severance payments, lower EBITDA, and higher working capital investment. The company acknowledges the volatility and lack of visibility in its main markets, which could impact future performance. Q & A Highlights Q: Can you elaborate on the additional savings identified for Project Cutting Edge and your confidence in achieving the $400 million target by 2027? A: The additional $50 million in savings primarily comes from transforming our organization, particularly through overhead headcount reductions. We are confident in achieving the $400 million target by 2027, as we have reviewed all initiatives to ensure they are recurrent. Out of the $400 million, $200 million relates to direct overhead personnel, with additional savings from indirect and non-personnel overheads, as well as operational efficiencies. Q: Could you provide more details on your strategy for building a shareholder return platform and your core market focus? A: Our strategy involves capital allocation decisions that prioritize shareholder returns. We plan to progressively increase dividends and consider opportunistic share buybacks as early as next year. Our core focus remains on the US, Mexico, and Europe, with potential divestitures in the South-Central America and Caribbean (SAC) region, which we consider "core-ish." Q: What are the key levers for free cash flow generation, and how do you plan to achieve structural improvements? A: We are working on multiple fronts, including reducing CapEx, achieving incremental savings from Project Cutting Edge, and boosting free cash flow from strategic CapEx projects. We also aim to reduce interest expenses and improve operational excellence. Portfolio rebalancing will take longer, but we have identified opportunities to enhance free cash flow conversion at a micro-market level. Q: Can you explain the new corporate structure and operating model, and how it supports improved free cash flow conversion? A: We are decentralizing operational excellence initiatives to the line, discontinuing centrally led initiatives, and boosting collaboration across regions. This approach optimizes resources, reduces costs, and enhances operational excellence, ultimately supporting improved free cash flow conversion. We aim to achieve a free cash flow conversion rate similar to industry peers by 2027. Q: What is the outlook for pricing trends in Mexico and the US for the rest of the year? A: In Mexico, we implemented a price increase effective July 1, expecting an $8 to $10 per ton increase. Year-to-date, ready-mix prices are up 7%, and aggregates are up 8%. In the US, we do not anticipate further cement price increases this year, with aggregates expected to remain around a 5% to 6% increase. Our pricing strategy aims to offset input cost inflation. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
26 minutes ago
- Yahoo
Deckers Outdoor Corp (DECK) Q1 2026 Earnings Call Highlights: Record Growth Driven by HOKA and ...
Revenue: Increased 17% year-over-year to $965 million. Diluted Earnings Per Share (EPS): Increased 24% to $0.93. HOKA Revenue: Increased 20% to $653 million, marking its largest quarter in history. UGG Revenue: Increased 19% to $265 million. International Revenue: Increased 50%, driven by HOKA and UGG. Gross Margin: 55.8%, down 110 basis points from the previous year. SG&A Expenses: $373 million, up 11% from the previous year, representing 38.6% of revenue. Cash and Equivalents: $1.7 billion as of June 30, 2025. Inventory: $849 million, up 13% year-over-year. Share Repurchase: Approximately $183 million worth of shares repurchased at an average price of $109.84 per share. Warning! GuruFocus has detected 3 Warning Signs with BANC. Release Date: July 24, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Deckers Outdoor Corp (NYSE:DECK) reported a strong start to fiscal year 2026, with revenue growing 17% year-over-year to $965 million. HOKA brand delivered its largest quarter in history, with global revenue increasing 20% to $653 million, driven by strong international growth. UGG brand also saw significant growth, with global revenue increasing 19% to $265 million, supported by strong wholesale performance. International markets contributed to a 50% increase in revenue, showcasing the global appeal and demand for DECK's brands. The company maintained a high degree of full-price integrity, indicating strong brand positioning and consumer demand. Negative Points Gross margin decreased by 110 basis points to 55.8%, impacted by unfavorable channel mix and increased promotional activity. The US market faced challenges, with ongoing pressure in the online channel and a choppy consumer environment. Higher freight rates and increased tariffs are expected to continue impacting gross margins throughout fiscal year 2026. Inventory levels increased by 13% year-over-year, which could pose a risk if consumer demand fluctuates. The company is not providing a formal outlook for fiscal year 2026 due to macroeconomic uncertainties, including global trade policy and consumer behavior. Q & A Highlights Q: Can you discuss the second-quarter guidance for HOKA, particularly the wholesale versus DTC channels, and the status of inventory for Bondi and Clifton models? A: Steven Fasching, CFO, explained that the 10% growth for HOKA considers some international timing on wholesale orders fulfilled in Q1. The growth is expected to be more balanced between wholesale and DTC in Q2, with improvements in DTC performance. Stefano Caroti, CEO, added that the market is largely clear of Bondi 8s and Clifton 9s, with Arahi 8 performing well. Q: How do you view the long-term DTC strategy for HOKA, given the current store footprint? A: Stefano Caroti, CEO, mentioned that HOKA has a small retail footprint with 48 stores globally and plans to expand, including new stores in Germany and Milan. The focus is on building brand awareness and consumer relationships through these retail locations. Q: Can you elaborate on the price increase strategy and its impact on the assortment? A: Stefano Caroti, CEO, stated that price increases are selective and staggered, with some implemented in July and others planned for spring. The strategy varies across brands and segments, focusing on protecting certain price points and franchises. Q: What insights are driving the focus on bolstering capabilities and spreading out product launches for HOKA? A: Stefano Caroti, CEO, highlighted the competitive landscape and the need to lead in innovation. The company is adding capabilities in design and engineering, spacing out key style launches, and creating more segmentation and differentiation for DTC. Q: How is the Board viewing the share buyback given the current cash position and valuation? A: Steven Fasching, CFO, noted that the company is sitting on a healthy cash position, which allows for share repurchase opportunities, especially when the stock is underappreciated. The Board will continue to evaluate buyback opportunities. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Betterware de Mexico SAPI de CV (BWMX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ...
Consolidated Revenue Growth: 5.1% year over year, 1.8% quarter on quarter. Betterware Mexico Revenue Growth: 4% quarter over quarter. Associate Base Growth: Increased from 1.12 million to 1.13 million, a 0.5% QoQ growth. Betterware Mexico EBITDA Margin: 19.9%. Jafra Mexico Revenue Growth: 10.9% year on year. Jafra Mexico EBITDA Margin: 21.2%. Jafra US Revenue Change: Decreased 8.9% year on year, 15.6% rebound quarter over quarter. Consolidated Gross Margin: 67.1%. Betterware Mexico Gross Margin: 55.2%, down 127 basis points year over year. Jafra Mexico Gross Margin: 75.3%, down 167 basis points year over year. Jafra US Gross Margin: Improved to 76%. Consolidated EBITDA: Increased 3.5% year over year to MXN679 million, margin of 19.1%. Free Cash Flow: Rose to MXN592 million, 87% conversion for the second quarter. Consolidated EPS Growth: 7.7% year over year. Net Debt-to-EBITDA Ratio: 1.97 times, down from 2.08 times in Q1 2025. Proposed Dividend: MXN200 million for Q2 2025. Warning! GuruFocus has detected 6 Warning Signs with BWMX. Release Date: July 24, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Betterware de Mexico SAPI de CV (NYSE:BWMX) reported a 5.1% year-over-year revenue growth and a 1.8% quarter-on-quarter increase, indicating a strong rebound from the previous quarter. The company achieved a 3.3% growth in its associate base, marking the first net associate growth since Q1 2021, which is crucial for driving team activity and retention. Jafra Mexico returned to profitability with a 10.9% year-on-year revenue increase and an EBITDA margin expansion to 21.2%, driven by successful rebranding efforts. The company launched Betterware Ecuador, surpassing its second-quarter goal with 2,500 active associates, showcasing successful geographic expansion. Free cash flow rose to MXN592 million, with a year-to-date conversion of 44.2% of EBITDA, indicating strong cash generation capabilities. Negative Points Betterware de Mexico SAPI de CV (NYSE:BWMX) experienced a 9.8% year-over-year revenue decline in Q1, highlighting previous challenges in the market. Jafra US saw an 8.9% year-on-year revenue decrease in US dollars, despite a 15.6% quarter-over-quarter rebound, indicating ongoing challenges in the US market. The company's gross margins were impacted by proactive pricing strategies, with Betterware Mexico's gross margin down 127 basis points year over year. Debt leverage remains higher than the previous year, with a net debt-to-EBITDA ratio of 1.97 times, up from 1.8 times in Q2 2024, due to incremental short-term debt. The macroeconomic environment remains uncertain, with potential challenges if the macro environment worsens, which could impact future growth projections. Q & A Highlights Q: How much of the sequential improvement in Q2 can be attributed to a better macro environment versus company-specific initiatives? A: Andres Campos, CEO, explained that while there was a slight stabilization or rebound in consumption, the improvement was primarily due to internal measures. The company focused on merchandising, pricing, and product strategies to make their portfolio more accessible, which significantly contributed to the strong Q2 results. Q: What are the key drivers to achieve the full-year guidance of 6% to 9% revenue and EBITDA growth? A: Andres Campos stated that they expect stability in the macroeconomic environment and consumption trends. The growth in associates for Betterware Mexico and Jafra Mexico, as well as Jafra US, is a positive sign. The company believes that with a stable macro environment, they can achieve the projected growth. Q: What efficiencies are being targeted to return Betterware to a 23% to 24% EBITDA margin? A: Andres Campos highlighted three factors: a strong peso against the dollar, lower freight costs, and an internal strategy to rely less on promotional activities that cut into margins. Additionally, continuous expense reduction and efficiency improvements are expected to drive EBITDA margin up. Q: What opportunities are there in the Chinese market given shifts in US production? A: Andres Campos noted opportunities to work more closely with suppliers and factories to improve product design and cost efficiency. While there isn't a significant change opening up new opportunities, these efforts are helping improve product costs and innovation capabilities. Q: How should inventory management be viewed for the rest of the year and into 2026? A: Rodrigo Munoz, CFO, stated that inventory levels are decreasing and are expected to continue declining. The strategy involves pushing existing inventory and reducing new purchases to return to normal inventory positions, improving productivity and efficiency. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
